NCT02815839View on ClinicalTrials.gov

Single Dose Study of SHR4640 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Gout; Hyperuricemia
Interventions
DRUG

SHR4640

DRUG

Placebo

Trial Locations (1)

400038

Southwest Hospital, Chongqing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02815839 - Single Dose Study of SHR4640 in Healthy Subjects | Biotech Hunter | Biotech Hunter